FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34808911000001109: Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105310201000001116 Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105310301000001113 Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Is a Reslizumab 25mg/2.5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has active ingredient Monoclonal antibody true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient Reslizumab true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Is a Cinqaero true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has AMP True Cinqaero 25mg/2.5ml concentrate for solution for infusion vials (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start